NEWSNATIONNOW (Zach Kaplan) - GLP-1 drugs linked to low blood pressure risk, Northwestern study finds
A senior author called the findings "statistically significant," citing the potential severity of low blood pressure events.
A senior author called the findings "statistically significant," citing the potential severity of low blood pressure events.
I have grave reservations about weight-loss drugs like Wegovy and Mounjaro, as you’ll know if you follow my work. Let’s set aside the basic moral […] Source
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won't cover it, you have options.
A growing number of GLP-1 users say they still see themselves as overweight even after losing significant weight. Experts call the phenomenon “ghost fat,” the latest psychological effect linked to the weight-loss revolution. Other reported side effects include “Ozempic face,” hair loss, muscle loss and mood changes.Do the benefits outweigh the side effects? And should the 41 million Americans using GLP-1 drugs be concerned?
A study found that stopping and restarting GLP-1s could make the drug less effective in weight loss.
The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects.
'Explosive, uncontrollable diarrhea'
Pfizer executives said most patients experienced few or mild side effects, with gastrointestinal events largely limited to early doses and clustered close to when patients received the shot.
A doctor's greater concern, she said, is not the drug itself but how patients obtain it.
The findings suggest GLP-1 drugs have anti-inflammatory and anti-tumor effects.